MedMira Inc. (TSXV:MIR)
0.0950
0.00 (0.00%)
Mar 28, 2025, 1:58 PM EST
MedMira Revenue
MedMira had revenue of 61.72K CAD in the quarter ending October 31, 2024, a decrease of -47.63%. This brings the company's revenue in the last twelve months to 356.43K, down -17.04% year-over-year. In the fiscal year ending July 31, 2024, MedMira had annual revenue of 412.57K, down -4.61%.
Revenue (ttm)
356.43K
Revenue Growth
-17.04%
P/S Ratio
187.01
Revenue / Employee
6.85K
Employees
52
Market Cap
66.66M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jul 31, 2024 | 412.57K | -19.96K | -4.61% |
Jul 31, 2023 | 432.53K | -519.60K | -54.57% |
Jul 31, 2022 | 952.13K | -1.19M | -55.60% |
Jul 31, 2021 | 2.14M | 1.23M | 133.33% |
Jul 31, 2020 | 919.07K | 391.63K | 74.25% |
Jul 31, 2019 | Pro | Pro | Pro |
Jul 31, 2018 | Pro | Pro | Pro |
Jul 31, 2017 | Pro | Pro | Pro |
Jul 31, 2016 | Pro | Pro | Pro |
Jul 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Green Thumb Industries | 1.64B |
dentalcorp Holdings | 1.55B |
Sienna Senior Living | 893.16M |
WELL Health Technologies | 957.69M |
Extendicare | 1.47B |
Curaleaf Holdings | 1.93B |
Trulieve Cannabis | 1.71B |
Cronos Group | 169.23M |
MedMira News
- 4 weeks ago - MedMira Announces Partnership with MediGroup Physician Services in the United States - Accesswire
- 4 weeks ago - MedMira Announces Exclusive Distribution Agreement with Trimedic Inc. for Canada - Accesswire
- 2 months ago - MedMira Receives Investigational Testing Authorizations for Multiplo(R) TP/HIV Self-Test and Non-Professional Use Applications - Accesswire
- 2 months ago - MedMira Receives Investigational Testing Authorizations for Multiplo(R) TP/HIV Self-Test and Non-Professional Use Applications - Accesswire
- 2 months ago - MedMira Receives Health Canada Approval for Its Reveal(R) G4 Rapid HIV-1/2 Test for Point-of-Care Use - Accesswire
- 2 months ago - MedMira Receives Health Canada Approval for Its Reveal(R) G4 Rapid HIV-1/2 Test for Point-of-Care Use - Accesswire
- 2 months ago - MedMira Receives Investigational Testing Authorization for its Multiplo(R) Complete Syphilis (TP/nTP) Antibody Test - Accesswire
- 3 months ago - MedMira Reports First Quarter Results FY2025 - Accesswire